Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Athanasios Seretis

3PUBLICATIONS

29CO-AUTHORS

Molecular targetsInnate immunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|May 07, 2025

Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma.

Athanasios Seretis, Lukas Amon, Christoph H Tripp

|Mar 29, 2025

Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockade.

Xavier Catena, Marta Contreras-Alcalde, Naiara Juan-Larrea

|Dec 21, 2021

Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor Langerin.

Lydia Bellmann, Helen Strandt, Claudia Zelle-Rieser

Pageof 1

Frequent Collaborators

2 joint publications

Daniela Ortner-Tobider

2 joint publications

Christoph H Tripp

2 joint publications

Giuseppe Cappellano

2 joint publications

Patrizia Stoitzner

1 joint publications

Lydia Bellmann

1 joint publications

Helen Strandt

1 joint publications

Claudia Zelle-Rieser

1 joint publications

Julia Rühl

1 joint publications

Sandra Schaffenrath

1 joint publications

Anastasia Prokopi

Frequent Collaborators

2 joint publications

Daniela Ortner-Tobider

2 joint publications

Christoph H Tripp

2 joint publications

Giuseppe Cappellano

2 joint publications

Patrizia Stoitzner

Top Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on : Jan 06, 2014

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells <em>In Vitro</em> and <em>In Vivo</em>

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 05, 2021

See more related videos

Top Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on : Jan 06, 2014

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells <em>In Vitro</em> and <em>In Vivo</em>

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 05, 2021

See more related videos